Bridgewater Associates’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,378
| Closed | -$266K | – | 797 |
|
|
2024
Q4 | $266K | Sell |
7,378
-18,257
| -71% | -$658K | ﹤0.01% | 642 |
|
|
2024
Q3 | $1.09M | Buy |
25,635
+13,299
| +108% | +$564K | 0.01% | 587 |
|
|
2024
Q2 | $497K | Sell |
12,336
-47,264
| -79% | -$1.9M | ﹤0.01% | 754 |
|
|
2024
Q1 | $2.11M | Sell |
59,600
-8,784
| -13% | -$311K | 0.01% | 492 |
|
|
2023
Q4 | $2.02M | Sell |
68,384
-9,175
| -12% | -$271K | 0.01% | 512 |
|
|
2023
Q3 | $1.61M | Buy |
77,559
+8,010
| +12% | +$166K | 0.01% | 532 |
|
|
2023
Q2 | $1.71M | Sell |
69,549
-9,435
| -12% | -$232K | 0.01% | 491 |
|
|
2023
Q1 | $3.21M | Buy |
78,984
+3,137
| +4% | +$127K | 0.02% | 381 |
|
|
2022
Q4 | $3.41M | Sell |
75,847
-25,896
| -25% | -$1.16M | 0.02% | 437 |
|
|
2022
Q3 | $4.87M | Buy |
101,743
+249
| +0.2% | +$11.9K | 0.02% | 384 |
|
|
2022
Q2 | $6.01M | Buy |
101,494
+9,244
| +10% | +$547K | 0.03% | 447 |
|
|
2022
Q1 | $10.7M | Buy |
92,250
+22,390
| +32% | +$2.6M | 0.04% | 288 |
|
|
2021
Q4 | $10.5M | Buy |
69,860
+12,252
| +21% | +$1.84M | 0.06% | 185 |
|
|
2021
Q3 | $6.88M | Sell |
57,608
-4,997
| -8% | -$597K | 0.04% | 249 |
|
|
2021
Q2 | $6.1M | Buy |
+62,605
| New | +$6.1M | 0.04% | 295 |
|